China Fudan University Cancer Hospital_A once yearly bone loss injection drug shows benefit for breast cancer patient (as low dose long term usage)

Breast Cancer Res Treat. 2010 Sep 30.

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.

 

http://www.ncbi.nlm.nih.gov/pubmed/20882405